Indo US Bio-Tech Ltd.

•
₹ 85.56-0.47%

2026-08-21

indousagriseeds.comBSE: 541304NSE: INDOUS
Market Cap₹ 173 Cr.
Current Price₹ 86
High / Low₹ 159 / 75
Stock P/E0.0
Book Value₹ 48
Price to Book3.76
Dividend Yield0.00 %
ROCE21.1 %
ROE23.0 %
Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2025 • Agriculture Activities: 73.7% • Trading Activity: 26.3%

PROS

  • Company has delivered good profit growth of 45.0% CAGR over last 5 years
  • Company has delivered good sales growth of 21.2% CAGR over last 5 years
  • Operating margins have improved to 18.2% from 14.2%
  • Company comfortably covers its interest (12.1x coverage)
  • Attractively priced for its growth - PEG of 0.4
  • Company maintains a comfortable, low leverage position

CONS

  • Recent results are weak - TTM profit is down 36.9% versus prior year
  • Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.08x)
  • Effective tax rate is unusually low at 1.6% - earnings may be flattered

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS
Fast Moving Consumer GoodsAgriAgriculture
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
1.KSCL768.9015.853955.150.00279.84-14.47742.50-13.5121.7739.58
2.VENKEYS1502.25308.042116.270.6749.99215.791118.3829.1711.276.18
3.AVTNPL87.1515.841327.160.9231.10156.69241.2282.1614.2616.56
4.REGAAL97.080.00999.860.26133.281369.952021.49719.8516.9115.33
5.BSHSL88.720.00931.000.0014.3016.56182.5719.3721.199.39
6.NATHBIOGEN154.007.99292.661.3032.26-13.46328.4015.766.8910.70
7.INDOUS86.2034.14172.850.003.04-35.3832.997.2121.1512.01
8.MSL145.0019.15159.210.003.971.9361.8425.8112.349.28
9.OSWALSEEDS13.309.96121.660.0012.2768.60117.0819.539.8815.65
10.NARMADA14.440.00110.770.007.54—222.63—8.944.25
11.AGRITECH101.300.0060.170.00-3.6161.180.00—-1.10—
12.ANTGRAPHIC0.730.0011.320.005.51695.09404.128005.09-1.591.46
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023
19
16
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
2
Tax %
2.86%
Net Profit
2
2
Equity Capital
10
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
10
Reserves
0
Promoter Pledge %
0.00%
Sep 2023
16
13
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
2
Tax %
15.66%
Net Profit
2
1
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Dec 2023
22
18
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
4
Tax %
1.87%
Net Profit
4
2
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Mar 2024
16
15
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
1
Tax %
17.46%
Net Profit
1
0
Equity Capital
20
Reserves
43
Promoter Pledge %
0.00%
Equity Capital
20
Reserves
43
Promoter Pledge %
0.00%
Jun 2024
25
21
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
3
Tax %
0.63%
Net Profit
3
2
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Sep 2024
22
17
Operating Profit
—
OPM %
—
Other Income
0
Interest
1
Depreciation
0
4
Tax %
2.02%
Net Profit
4
2
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Dec 2024
24
18
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
5
Tax %
-0.80%
Net Profit
5
3
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Mar 2025
33
29
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
1
4
Tax %
4.90%
Net Profit
4
2
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Jun 2025
31
25
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
5
Tax %
2.49%
Net Profit
5
2
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Sep 2025
31
27
Operating Profit
—
OPM %
—
Other Income
0
Interest
0
Depreciation
0
4
Tax %
3.09%
Net Profit
3
2
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Dec 2025
23
19
Operating Profit
—
OPM %
—
Other Income
0
Interest
1
Depreciation
0
3
Tax %
5.38%
Net Profit
3
1
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Mar 2026
26
23
Operating Profit
—
OPM %
—
Other Income
0
Interest
1
Depreciation
0
2
Tax %
17.23%
Net Profit
2
1
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Jun 2026
33
30
Operating Profit
—
OPM %
—
Other Income
0
Interest
1
Depreciation
0
3
Tax %
1.30%
Net Profit
3
0
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016
19
19
Operating Profit
1
OPM %
3
Other Income
0
Interest
0
Depreciation
0
0
Tax %
-50
Net Profit
0
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
0
Mar 2017
25
23
Operating Profit
1
OPM %
5
Other Income
0
Interest
1
Depreciation
0
1
Tax %
24
Net Profit
0
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
0
Mar 2018
30
27
Operating Profit
3
OPM %
10
Other Income
0
Interest
1
Depreciation
0
2
Tax %
29
Net Profit
1
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
1
Minority Interest
0
Share of Associates
0
Adjusted EPS
1
Mar 2019
35
32
Operating Profit
3
OPM %
10
Other Income
0
Interest
0
Depreciation
0
3
Tax %
26
Net Profit
2
EPS
0
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
1
Minority Interest
0
Share of Associates
0
Adjusted EPS
1
Mar 2020
40
36
Operating Profit
4
OPM %
10
Other Income
0
Interest
1
Depreciation
0
3
Tax %
11
Net Profit
3
EPS
4
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Mar 2021
40
35
Operating Profit
6
OPM %
14
Other Income
0
Interest
1
Depreciation
0
4
Tax %
-24
Net Profit
5
EPS
8
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
4
Minority Interest
0
Share of Associates
0
Adjusted EPS
4
Mar 2022
50
43
Operating Profit
7
OPM %
14
Other Income
0
Interest
1
Depreciation
0
5
Tax %
5
Net Profit
5
EPS
9
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
3
Minority Interest
0
Share of Associates
0
Adjusted EPS
3
Mar 2023
62
52
Operating Profit
9
OPM %
15
Other Income
0
Interest
1
Depreciation
1
7
Tax %
2
Net Profit
7
EPS
8
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
4
Minority Interest
0
Share of Associates
0
Adjusted EPS
4
Mar 2024
73
62
Operating Profit
11
OPM %
15
Other Income
0
Interest
2
Depreciation
1
9
Tax %
6
Net Profit
8
EPS
4
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
4
Minority Interest
0
Share of Associates
0
Adjusted EPS
4
Mar 2025
104
85
Operating Profit
19
OPM %
18
Other Income
0
Interest
1
Depreciation
1
17
Tax %
2
Net Profit
16
EPS
8
Dividend Payout %
3
Minority Interest
0
Share of Associates
0
Adjusted EPS
8
Minority Interest
0
Share of Associates
0
Adjusted EPS
8
TTM
113
98
Operating Profit
—
OPM %
—
Other Income
0
Interest
3
Depreciation
1
12
Tax %
6
Net Profit
11
EPS
—
Dividend Payout %
—
Minority Interest
0
Share of Associates
0
Adjusted EPS
—
Minority Interest
0
Share of Associates
0
Adjusted EPS
—

COMPOUNDED SALES GROWTH

10 Years:
18%
5 Years:
21%
3 Years:
28%

COMPOUNDED PROFIT GROWTH

10 Years:
42%
5 Years:
45%
3 Years:
46%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
-43%

RETURN ON EQUITY

10 Years:
19%
5 Years:
19%
3 Years:
18%
Last Year:
23%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2023

Aug 29

1:1

Increase in Authorised Capital & Bonus issue & Inter alia, to consider and approve :- (1) To increase Authorised Share Capital of the Company. (2) To recommend for the Issue of Bonus Shares to the existing Shareholders of the company. (3) To Call the Extra Ordinary General Meeting for the purpose of approval of above agendas. (4) Any other Matter with the permission of the Chair.

2021

Nov 29

1:5

2019

Apr 23

1:4

Bonus issue & Increase in Authorised Capital The Company is going to discuss about following main agenda. 1. To Increase Authorized Share Capital of the Company. 2. To discuss and approve the Issue of Bonus Shares which will be Subject to approval of the Shareholders at General Meeting. 3. To take note of Resignation of Mr. Dhiren Vithaldas Savalia from the post of Independent Director of the Company.

Mar 2016
Equity Capital
1
2
4
Trade Payables
5
0
Total Liabilities
13
1
Capital Work in Progress
0
5
0
Cash & Bank
0
7
Total Assets
13
Total Debt
5
Net Working Capital
2
Contingent Liabilities
0
Book Value per Share
21.86
Face Value
10.00
Total Debt
5
Net Working Capital
2
Contingent Liabilities
0
Book Value per Share
21.86
Face Value
10.00
Mar 2017
Equity Capital
1
2
4
Trade Payables
4
1
Total Liabilities
12
1
Capital Work in Progress
0
5
0
Cash & Bank
0
6
Total Assets
12
Total Debt
5
Net Working Capital
2
Contingent Liabilities
0
Book Value per Share
23.46
Face Value
10.00
Total Debt
5
Net Working Capital
2
Contingent Liabilities
0
Book Value per Share
23.46
Face Value
10.00
Mar 2018
Equity Capital
3
2
5
Trade Payables
5
3
Total Liabilities
17
2
Capital Work in Progress
0
6
0
Cash & Bank
0
9
Total Assets
17
Total Debt
7
Net Working Capital
5
Contingent Liabilities
0
Book Value per Share
14.43
Face Value
10.00
Total Debt
7
Net Working Capital
5
Contingent Liabilities
0
Book Value per Share
14.43
Face Value
10.00
Mar 2019
Equity Capital
5
9
5
Trade Payables
2
3
Total Liabilities
24
1
Capital Work in Progress
1
11
0
Cash & Bank
0
11
Total Assets
24
Total Debt
6
Net Working Capital
13
Contingent Liabilities
0
Book Value per Share
28.56
Face Value
10.00
Total Debt
6
Net Working Capital
13
Contingent Liabilities
0
Book Value per Share
28.56
Face Value
10.00
Mar 2020
Equity Capital
6
10
7
Trade Payables
8
3
Total Liabilities
35
1
Capital Work in Progress
1
9
0
Cash & Bank
0
23
Total Assets
35
Total Debt
9
Net Working Capital
15
Contingent Liabilities
0
Book Value per Share
27.05
Face Value
10.00
Total Debt
9
Net Working Capital
15
Contingent Liabilities
0
Book Value per Share
27.05
Face Value
10.00
Mar 2021
Equity Capital
6
15
8
Trade Payables
9
5
Total Liabilities
43
2
Capital Work in Progress
2
12
0
Cash & Bank
0
27
Total Assets
43
Total Debt
11
Net Working Capital
20
Contingent Liabilities
1
Book Value per Share
35.47
Face Value
10.00
Total Debt
11
Net Working Capital
20
Contingent Liabilities
1
Book Value per Share
35.47
Face Value
10.00
Mar 2022
Equity Capital
9
30
8
Trade Payables
2
6
Total Liabilities
55
6
Capital Work in Progress
2
23
0
Cash & Bank
0
24
Total Assets
55
Total Debt
13
Net Working Capital
35
Contingent Liabilities
1
Book Value per Share
42.41
Face Value
10.00
Total Debt
13
Net Working Capital
35
Contingent Liabilities
1
Book Value per Share
42.41
Face Value
10.00
Mar 2023
Equity Capital
10
44
9
Trade Payables
1
4
Total Liabilities
69
7
Capital Work in Progress
1
27
0
Cash & Bank
0
33
Total Assets
69
Total Debt
12
Net Working Capital
48
Contingent Liabilities
1
Book Value per Share
54.35
Face Value
10.00
Total Debt
12
Net Working Capital
48
Contingent Liabilities
1
Book Value per Share
54.35
Face Value
10.00
Mar 2024
Equity Capital
20
43
10
Trade Payables
4
6
Total Liabilities
84
7
Capital Work in Progress
4
52
19
Cash & Bank
1
1
Total Assets
84
Total Debt
14
Net Working Capital
56
Contingent Liabilities
1
Book Value per Share
31.29
Face Value
10.00
Total Debt
14
Net Working Capital
56
Contingent Liabilities
1
Book Value per Share
31.29
Face Value
10.00
Mar 2025
Equity Capital
20
58
10
Trade Payables
1
7
Total Liabilities
97
10
Capital Work in Progress
0
71
15
Cash & Bank
0
1
Total Assets
97
Total Debt
15
Net Working Capital
70
Contingent Liabilities
0
Book Value per Share
39.16
Face Value
10.00
Total Debt
15
Net Working Capital
70
Contingent Liabilities
0
Book Value per Share
39.16
Face Value
10.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016
-3
Cash from Investing
-0
Cash from Financing
3
0
Free Cash Flow
-3
OCF / Net Profit
-7.16
Cumulative 5-Year FCF
0
OCF / Net Profit
-7.16
Cumulative 5-Year FCF
0
Mar 2017
0
Cash from Investing
-0
Cash from Financing
0
-0
Free Cash Flow
-0
OCF / Net Profit
0.17
Cumulative 5-Year FCF
0
OCF / Net Profit
0.17
Cumulative 5-Year FCF
0
Mar 2018
-1
Cash from Investing
0
Cash from Financing
1
0
Free Cash Flow
-1
OCF / Net Profit
-0.61
Cumulative 5-Year FCF
0
OCF / Net Profit
-0.61
Cumulative 5-Year FCF
0
Mar 2019
-3
Cash from Investing
-3
Cash from Financing
6
0
Free Cash Flow
-5
OCF / Net Profit
-1.52
Cumulative 5-Year FCF
0
OCF / Net Profit
-1.52
Cumulative 5-Year FCF
0
Mar 2020
-1
Cash from Investing
-1
Cash from Financing
2
0
Free Cash Flow
-1
OCF / Net Profit
-0.33
Cumulative 5-Year FCF
-10
OCF / Net Profit
-0.33
Cumulative 5-Year FCF
-10
Mar 2021
0
Cash from Investing
-2
Cash from Financing
1
-0
Free Cash Flow
-1
OCF / Net Profit
0.04
Cumulative 5-Year FCF
-9
OCF / Net Profit
0.04
Cumulative 5-Year FCF
-9
Mar 2022
3
Cash from Investing
-5
Cash from Financing
2
-0
Free Cash Flow
-1
OCF / Net Profit
0.56
Cumulative 5-Year FCF
-9
OCF / Net Profit
0.56
Cumulative 5-Year FCF
-9
Mar 2023
1
Cash from Investing
-7
Cash from Financing
6
0
Free Cash Flow
-0
OCF / Net Profit
0.07
Cumulative 5-Year FCF
-9
OCF / Net Profit
0.07
Cumulative 5-Year FCF
-9
Mar 2024
-5
Cash from Investing
4
Cash from Financing
1
1
Free Cash Flow
-6
OCF / Net Profit
-0.56
Cumulative 5-Year FCF
-10
OCF / Net Profit
-0.56
Cumulative 5-Year FCF
-10
Mar 2025
1
Cash from Investing
-1
Cash from Financing
-1
-1
Free Cash Flow
-3
OCF / Net Profit
0.09
Cumulative 5-Year FCF
-11
OCF / Net Profit
0.09
Cumulative 5-Year FCF
-11

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016
EPS (₹)
2.42
Book Value (₹)
21.86
Dividend per Share (₹)
0.00
Cash EPS (₹)
0.49
Operating Margin %
3.16%
Net Margin %
1.89%
ROE %
11.69%
ROCE %
7.39%
3.55%
Debtor Days
66
Inventory Days
91
Payable Days
86
71
Debt to Equity (x)
1.44x
Interest Coverage (x)
2.08x
1.18x
Revenue Growth %
-2.69%
Operating Profit Growth %
-13.20%
Net Profit Growth %
-27.42%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2017
EPS (₹)
2.66
Book Value (₹)
23.46
Dividend per Share (₹)
0.00
Cash EPS (₹)
0.53
Operating Margin %
5.33%
Net Margin %
1.62%
ROE %
11.74%
ROCE %
14.24%
3.14%
Debtor Days
79
Inventory Days
78
Payable Days
79
78
Debt to Equity (x)
1.39x
Interest Coverage (x)
1.82x
1.27x
Revenue Growth %
28.66%
Operating Profit Growth %
117.24%
Net Profit Growth %
10.06%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2018
EPS (₹)
4.23
Book Value (₹)
14.43
Dividend per Share (₹)
0.00
Cash EPS (₹)
1.56
Operating Margin %
9.84%
Net Margin %
4.89%
ROE %
34.36%
ROCE %
27.84%
10.01%
Debtor Days
87
Inventory Days
70
Payable Days
64
93
Debt to Equity (x)
1.32x
Interest Coverage (x)
3.83x
1.47x
Revenue Growth %
20.85%
Operating Profit Growth %
123.09%
Net Profit Growth %
265.83%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2019
EPS (₹)
4.30
Book Value (₹)
28.56
Dividend per Share (₹)
0.00
Cash EPS (₹)
1.60
Operating Margin %
9.71%
Net Margin %
5.88%
ROE %
22.21%
ROCE %
20.35%
10.26%
Debtor Days
93
Inventory Days
87
Payable Days
54
126
Debt to Equity (x)
0.45x
Interest Coverage (x)
8.10x
2.45x
Revenue Growth %
19.82%
Operating Profit Growth %
18.23%
Net Profit Growth %
44.11%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2020
EPS (₹)
4.18
Book Value (₹)
27.05
Dividend per Share (₹)
0.00
Cash EPS (₹)
1.89
Operating Margin %
9.99%
Net Margin %
6.37%
ROE %
16.74%
ROCE %
16.65%
8.66%
Debtor Days
138
Inventory Days
91
Payable Days
418
-189
Debt to Equity (x)
0.52x
Interest Coverage (x)
4.24x
1.91x
Revenue Growth %
12.03%
Operating Profit Growth %
15.23%
Net Profit Growth %
21.38%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2021
EPS (₹)
8.40
Book Value (₹)
35.47
Dividend per Share (₹)
0.00
Cash EPS (₹)
3.67
Operating Margin %
13.86%
Net Margin %
12.72%
ROE %
26.87%
ROCE %
18.30%
13.05%
Debtor Days
208
Inventory Days
96
Payable Days
0
304
Debt to Equity (x)
0.53x
Interest Coverage (x)
4.50x
2.12x
Revenue Growth %
0.82%
Operating Profit Growth %
39.92%
Net Profit Growth %
101.13%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2022
EPS (₹)
5.71
Book Value (₹)
42.41
Dividend per Share (₹)
0.00
Cash EPS (₹)
3.09
Operating Margin %
14.21%
Net Margin %
10.46%
ROE %
17.34%
ROCE %
15.86%
10.63%
Debtor Days
165
Inventory Days
128
Payable Days
-223
516
Debt to Equity (x)
0.32x
Interest Coverage (x)
5.57x
3.85x
Revenue Growth %
24.86%
Operating Profit Growth %
28.02%
Net Profit Growth %
2.73%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2023
EPS (₹)
7.22
Book Value (₹)
54.35
Dividend per Share (₹)
0.00
Cash EPS (₹)
4.02
Operating Margin %
15.25%
Net Margin %
11.73%
ROE %
15.51%
ROCE %
14.62%
11.67%
Debtor Days
134
Inventory Days
149
Payable Days
302
-20
Debt to Equity (x)
0.21x
Interest Coverage (x)
7.15x
4.87x
Revenue Growth %
23.36%
Operating Profit Growth %
32.33%
Net Profit Growth %
38.25%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2024
EPS (₹)
4.12
Book Value (₹)
31.29
Dividend per Share (₹)
0.00
Cash EPS (₹)
4.51
Operating Margin %
14.83%
Net Margin %
11.33%
ROE %
14.08%
ROCE %
14.42%
10.81%
Debtor Days
110
Inventory Days
197
Payable Days
-54
361
Debt to Equity (x)
0.23x
Interest Coverage (x)
6.79x
4.19x
Revenue Growth %
17.96%
Operating Profit Growth %
18.17%
Net Profit Growth %
13.96%
-43.02%
P/E (x)
53.94x
P/B (x)
7.09x
Dividend Yield %
0.00%
41.20x
Mar 2025
EPS (₹)
8.11
Book Value (₹)
39.16
Dividend per Share (₹)
0.25
Cash EPS (₹)
8.66
Operating Margin %
18.24%
Net Margin %
15.67%
ROE %
23.03%
ROCE %
21.15%
17.98%
Debtor Days
60
Inventory Days
215
Payable Days
598
-323
Debt to Equity (x)
0.19x
Interest Coverage (x)
12.09x
5.31x
Revenue Growth %
42.56%
Operating Profit Growth %
71.86%
Net Profit Growth %
97.15%
97.15%
P/E (x)
18.15x
P/B (x)
3.76x
Dividend Yield %
0.17%
16.21x

Shareholding Pattern

Numbers in percentages

TRADES
Jun 2024
70.17
0.00
DIIs
0.00
Government
0.00
29.83
Sep 2024
70.17
0.00
DIIs
0.00
Government
0.00
29.83
Dec 2024
70.17
0.00
DIIs
0.00
Government
0.00
29.82
Mar 2025
70.17
0.00
DIIs
0.00
Government
0.00
29.83
Jun 2025
70.17
0.00
DIIs
0.00
Government
0.00
29.83
Sep 2025
70.17
0.00
DIIs
0.00
Government
0.00
29.83
Dec 2025
70.17
0.00
DIIs
0.00
Government
0.00
29.83
Mar 2026
68.29
0.18
DIIs
0.00
Government
0.00
31.53
Jun 2026
68.29
0.01
DIIs
0.00
Government
0.00
31.70

Documents

Announcements

  • Copy of Newspaper Publication

    2026-08-13 - Indo Us Biotech Limited has informed the Exchange about Copy of Newspaper Publication relating to unaudited quarterly Financial Results for the quarter ended on 30th June, 2026

  • Integrated Filing- Financial

    2026-08-12 - Submission of Standalone Unaudited Financial Results of the Company for the quarter ended June 30, 2026.

Annual Reports

Credit Ratings

Nothing filed yet.

Concalls

Nothing filed yet.